Maralixibat
( DrugBank: Maralixibat / KEGG DRUG: Maralixibat, Maralixibat chloride )
4 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
296 | Biliary atresia | 8 |
297 | Alagille syndrome | 16 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
299 | Cystic fibrosis | 1 |
338 | Progressive familial intrahepatic cholestasis | 32 |
296. Biliary atresia
Clinical trials : 73 / Drugs : 67 - (DrugBank : 36) / Drug target genes : 51 - Drug target pathways : 68
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
297. Alagille syndrome
Clinical trials : 45 / Drugs : 15 - (DrugBank : 8) / Drug target genes : 3 - Drug target pathways : 5
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
299. Cystic fibrosis
Clinical trials : 1,826 / Drugs : 1,271 - (DrugBank : 246) / Drug target genes : 118 - Drug target pathways : 180
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
338. Progressive familial intrahepatic cholestasis
Clinical trials : 62 / Drugs : 14 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 3
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|